Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck
暂无分享,去创建一个
R. Seethala | J. Paydarfar | I. Brčić | V. Deshpande | D. Pastel | L. Thompson | L. Tafe | K. Shirai | I. John | J. Bridge | K. Linos | D. Kerr | V. Jo | C. Salgado | K. Kashofer | Azfar Neyaz | Prashanthi Divakar | Darcy A. Kerr
[1] Carmen Rodríguez-Jiménez,et al. Novel SLC12A2‐ROS1 Fusion in Non‐Small Cell Lung Cancer with a Significant Response to Crizotinib: The Importance of Choosing the Appropriate Next‐Generation Sequencing Assay , 2021, The oncologist.
[2] B. Wenig,et al. The Most Common Mistake in Laryngeal Pathology and How to Avoid it , 2021, Head and Neck Pathology.
[3] K. Perry,et al. “Inflammatory Leiomyosarcoma” and “Histiocyte-rich Rhabdomyoblastic Tumor”: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as “Inflammatory Rhabdomyoblastic Tumor” , 2020, Modern Pathology.
[4] D. Roberts,et al. Inflammatory Myofibroblastic Tumors associated with the placenta, a series of 9 cases. , 2020, Human pathology.
[5] L. Vaickus,et al. Fine needle aspiration of an intranodal follicular dendritic cell sarcoma: A case report with molecular analysis and review of the literature , 2020, Diagnostic cytopathology.
[6] Masayuki Yoshida,et al. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology. , 2020, The American journal of surgical pathology.
[7] A. Folpe,et al. Well-Differentiated/Dedifferentiated Liposarcoma Arising in the Upper Aerodigestive Tract: 8 Cases Mimicking Non-adipocytic Lesions , 2020, Head and Neck Pathology.
[8] C. Kunder,et al. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions , 2020, The American journal of surgical pathology.
[9] B. Rubin,et al. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor , 2020, Virchows Archiv.
[10] E. Imyanitov,et al. Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors , 2020, Pediatric blood & cancer.
[11] A. Clayton,et al. Uterine inflammatory Myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of six cases with identification of a novel TIMP3-RET fusion. , 2020, Human pathology.
[12] S. Salas,et al. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation , 2019, Modern Pathology.
[13] Y. Oda,et al. Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3–ALK fusion: A potential diagnostic pitfall , 2019, Pathology international.
[14] F. Mertens,et al. Gene fusion involving the insulin‐like growth factor 1 receptor in an ALK‐negative inflammatory myofibroblastic tumour , 2019, Histopathology.
[15] S. Yuen,et al. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion , 2018, Modern Pathology.
[16] L. Le,et al. Morphologic Overlap Between Inflammatory Myofibroblastic Tumor and IgG4-related Disease: Lessons From Next-generation Sequencing , 2018, The American journal of surgical pathology.
[17] M. Levy,et al. A novel KIF5B-ALK fusion in a child with an atypical central nervous system inflammatory myofibroblastic tumour , 2018, BMJ Case Reports.
[18] Asha A. Nair,et al. Spindle cell rhabdomyosarcoma of bone with FUS–TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype , 2018, Histopathology.
[19] O. Delattre,et al. Transcriptomic definition of molecular subgroups of small round cell sarcomas , 2018, The Journal of pathology.
[20] H. Qin,et al. ALK‐rearrangement in non‐small‐cell lung cancer (NSCLC) , 2018, Thoracic cancer.
[21] E. Oliva,et al. Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum , 2017, Modern Pathology.
[22] Y. Oda,et al. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours , 2016, Histopathology.
[23] Gary K. Schwartz,et al. Alternative transcription initiation leads to expression of a novel ALK isoform in cancer , 2015, Nature.
[24] C. Antonescu,et al. Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement , 2015, The American journal of surgical pathology.
[25] Shuihong Zhou,et al. Inflammatory myofibroblastic tumors of the head and nec. , 2015, International journal of clinical and experimental medicine.
[26] P. Cin,et al. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors , 2015, Modern Pathology.
[27] Jeffrey W. Clark,et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. , 2014, The New England journal of medicine.
[28] P. Stephens,et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. , 2014, Cancer discovery.
[29] R. Doebele,et al. Molecular Pathways Molecular Pathways : ROS 1 Fusion Proteins in Cancer , 2013 .
[30] F. Cappuzzo,et al. Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer , 2012, Clinical Cancer Research.
[31] Z. Tothova,et al. Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors , 2012, Current opinion in oncology.
[32] Yuki Togashi,et al. RET, ROS1 and ALK fusions in lung cancer , 2012, Nature Medicine.
[33] Y. Ishikawa,et al. Pulmonary Inflammatory Myofibroblastic Tumor Expressing a Novel Fusion, PPFIBP1–ALK: Reappraisal of Anti-ALK Immunohistochemistry as a Tool for Novel ALK Fusion Identification , 2011, Clinical Cancer Research.
[34] Wei-Lien Wang,et al. Epithelioid Inflammatory Myofibroblastic Sarcoma: An Aggressive Intra-abdominal Variant of Inflammatory Myofibroblastic Tumor With Nuclear Membrane or Perinuclear ALK , 2011, The American journal of surgical pathology.
[35] Marc Ladanyi,et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. , 2010, The New England journal of medicine.
[36] R. Kumar,et al. Inflammatory myofibroblastic tumour , 2010, European Respiratory Journal.
[37] Y. Ishikawa,et al. KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer , 2009, Clinical Cancer Research.
[38] J. Hornick,et al. Inflammatory myofibroblastic tumours: where are we now? , 2007, Journal of Clinical Pathology.
[39] C. Fletcher,et al. Inflammatory Myofibroblastic Tumor: Comparison of Clinicopathologic, Histologic, and Immunohistochemical Features Including ALK Expression in Atypical and Aggressive Cases , 2007, The American journal of surgical pathology.
[40] Y. Oda,et al. Absence of human herpesvirus‐8 and Epstein–Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene , 2006, Pathology international.
[41] W. Sanger,et al. Expression of ALK1 and p80 in Inflammatory Myofibroblastic Tumor and Its Mesenchymal Mimics: A Study of 135 Cases , 2002, Modern Pathology.
[42] P. Marynen,et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large‐cell lymphoma and inflammatory myofibroblastic tumor , 2002, Genes, chromosomes & cancer.
[43] S. Morris,et al. Anaplastic Lymphoma Kinase (ALK) Expression in the Inflammatory Myofibroblastic Tumor: A Comparative Immunohistochemical Study , 2001, The American journal of surgical pathology.
[44] S. Tripp,et al. Are Myogenin and MyoD1 Expression Specific for Rhabdomyosarcoma?: A Study of 150 Cases, With Emphasis on Spindle Cell Mimics , 2001, The American journal of surgical pathology.
[45] P. D. Dal Cin,et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. , 2000, The American journal of pathology.
[46] Louis P. Dehner,et al. Extrapulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) A Clinicopathologic and Immunohistochemical Study of 84 Cases , 1995, The American journal of surgical pathology.
[47] F. Mertens,et al. Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature , 2018, Modern Pathology.
[48] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[49] I. Kazantseva,et al. [Extrapulmonary inflammatory myofibroblastic tumor]. , 2001, Arkhiv patologii.